Literature DB >> 11583007

Susceptibilities of Propionibacterium acnes ophthalmic isolates to moxifloxacin.

P Dali, E R Giugliano, E M Vellozzi, M A Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583007      PMCID: PMC90767          DOI: 10.1128/AAC.45.10.2969-2970.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria.

Authors:  A P MacGowan; K E Bowker; H A Holt; M Wootton; D S Reeves
Journal:  J Antimicrob Chemother       Date:  1997-10       Impact factor: 5.790

2.  Susceptibility testing of Propionibacterium acnes comparing agar dilution with E test.

Authors:  M A Smith; P Alperstein; K France; E M Vellozzi; H D Isenberg
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

3.  Evaluation of the E test for susceptibility testing of anaerobic bacteria.

Authors:  D M Citron; M I Ostovari; A Karlsson; E J Goldstein
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

4.  Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.

Authors:  C Edlund; S Sabouri; C E Nord
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

  4 in total
  2 in total

1.  Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime.

Authors:  Robert Shames; Farhana Satti; Ernestine M Vellozzi; Miriam A Smith
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

2.  Metagenomic Human Repiratory Air in a Hospital Environment.

Authors:  Yi Yu Lai; Yanming Li; Jidong Lang; Xunliang Tong; Lina Zhang; Jianhuo Fang; Jingli Xing; Meng Cai; Hongtao Xu; Yan Deng; Fei Xiao; Geng Tian
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.